1. Chinese herbal medicine and its active compounds in attenuating renal injury via regulating autophagy in diabetic kidney disease
   Peng Liu et al, 2023, Front. Endocrinol. CrossRef
2. Bioinformatics analysis of potential key ferroptosis-related genes involved in tubulointerstitial injury in patients with diabetic nephropathy
   Li-Li Ma et al, 2023, Renal Failure CrossRef
3. Formyl Peptide Receptor 2-Dependent cPLA2 and 5-LOX Activation Requires a Functional NADPH Oxidase
   Tiziana Pecchillo Cimmino et al, 2024, Antioxidants CrossRef
4. Mangiferin, a Potential Supplement to Improve Metabolic Syndrome: Current Status and Future Opportunities
   Gelin Xiang et al, 2024, Am. J. Chin. Med. CrossRef
5. Loureirin B improves H/R-induced hepatic ischemia–reperfusion injury by downregulating ALOX5 to regulate mitochondrial homeostasis
   Zhaolong Yu et al, 2024, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
6. Identification of potential key lipid metabolism-related genes involved in tubular injury in diabetic kidney disease by bioinformatics analysis
   Yuanshuo Fan et al, 2024, Acta Diabetol CrossRef
7. Unveiling the substantial role of rutin in the management of drug-induced nephropathy using network pharmacology and molecular docking
   Prashant Thakur et al, 2025, International Immunopharmacology CrossRef